OPRA vs GENI
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
OPRA · Opera$12.86 ▼ 5.02%
GENI · Genius Sports$5.18 ▼ 11.00%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- OPRA +0.2%
- GENI -43.3%
Head to head
| Metric | OPRA | GENI |
|---|---|---|
| Price | $12.86 | $5.18 |
| Change today | ▼ 5.02% | ▼ 11.00% |
| Market cap | $1.12B | $1.39B |
| Return, 3 months | -31.8% | -35.2% |
| Return, year to date | -4.8% | -53.0% |
| Return, 1 year | +4.0% | -43.0% |
| P/E (TTM) | 8.6 | – |
| P/B | 1.1 | 2.0 |
| P/E percentile vs own 5y | 48th | 47th |
| Dividend yield | 6.22% | – |
| Revenue growth (YoY, latest qtr) | +24.6% | +62.3% |
| Net profit growth (YoY) | +75.7% | +45.5% |
| Gross margin | 63.2% | 29.9% |
| Operating margin | 16.3% | -8.0% |
| Net margin | 18.5% | -18.9% |
| Return on equity | 12.9% | -23.9% |
| Analyst target vs. price | +108.6% | +86.3% |
| Analyst buy share | 100% | 82% |
| RSI (14) | 27 | 34 |
| 30-day volatility | 62.3% | 78.2% |
| Max drawdown, 1 year | -37.3% | -65.5% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- GENI is the largest of the group by market value.
- OPRA has returned the most over the past year.
- GENI is growing revenue fastest.
- OPRA keeps the most profit per dollar of sales.
- OPRA has been the calmest stock over the last 30 days.